Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-on To Metformin Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) for Patients With Type 2 Diabetes Mellitus (T2dm) In The UK
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.729
https://www.valueinhealthjournal.com/article/S1098-3015(14)02659-X/fulltext
Title :
Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-on To Metformin Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) for Patients With Type 2 Diabetes Mellitus (T2dm) In The UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02659-X&doi=10.1016/j.jval.2014.08.729
First page :
A350
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
150